Atrial Arrhythmia |
Atrial Arrhythmia research study
What is the primary objective of this study?
The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.
Who is eligible to participate?
Inclusion Criteria: - Patient implanted (primo-implant, replacement, upgrade) with dual chamber pacemaker from less than two months or implanted at inclusion. Exclusion Criteria: - Contraindicated for cardiac pacing, according to the ESC and ACC/AHA/HRS guidelines - Permanent or persistent atrial tachyarrhythmia
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: March 2010
Completed Date: August 31, 2017
Primary Outcome: Atrial arrhythmias incidence
Study sponsors, principal investigator, and references
Lead Sponsor: LivaNova